Company / Total Assets
Amgen Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$90.6B
FY2025
5-year range
$61.2B / $97.2B
FY2021-FY2025
Trend
-1.4%
vs FY2024
Sector context
#6 of 216
Health Care
What the data says
Among 216 Health Care companies, Amgen is in the top 3% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $59.7B in FY2019 to $97.2B in FY2023.
Based on SEC 10-K filings.
$90.6B in FY2025 with a 5-year CAGR of +7.6%. Top quartile in the Health Care sector.
Declined from $97.2B to $90.6B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +11.6%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 216This company $90.6B Sector average $7.4B
▼
+1116.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.6%, indicating consistent growth.
- In FY2025, total assets decreased 1.4% year-over-year.
- Ranks #6 out of 216 companies in the Health Care sector.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $90.6B | -1.4% |
| FY2024 | $91.8B | -5.5% |
| FY2023 | $97.2B | +49.2% |
| FY2022 | $65.1B | +6.5% |
| FY2021 | $61.2B | -2.8% |
| FY2020 | $62.9B | +5.4% |
| FY2019 | $59.7B | -10.1% |
| FY2018 | $66.4B | -16.9% |
| FY2017 | $80.0B | +3.0% |
| FY2016 | $77.6B | +8.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026